First Foundation Advisors Johnson & Johnson Transaction History

First Foundation Advisors

$2.58 Billion
Q3 2024

A detailed history of First Foundation Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, First Foundation Advisors holds 50,725 shares of JNJ stock, worth $7.84 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

50,725

Previous 50,940 0.42%

Holding current value

$7.84 Million

Previous $7.45 Million 10.41%

% of portfolio

0.32%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $31,278 - $35,986	-215 Reduced 0.42%	50,725 $8.22 Million
Q2 2024 Aug 06, 2024	BUY	$144.38 - $157.78 $857,328 - $936,897	5,938 Added 13.19%	50,940 $7.45 Million
Q1 2024 May 09, 2024	BUY	$155.22 - $162.74 $819,406 - $859,104	5,279 Added 13.29%	45,002 $7.12 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $1.93 Million - $2.11 Million	-13,283 Reduced 25.06%	39,723 $6.23 Million
Q3 2023 Nov 15, 2023	BUY	$155.75 - $174.48 $251,224 - $281,436	1,613 Added 3.14%	53,006 $8.26 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $1.43 Million - $1.54 Million	9,297 Added 22.09%	51,393 $8.51 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $312,522 - $372,957	2,069 Added 5.17%	42,096 $6.52 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $662,907 - $743,971	4,138 Added 11.53%	40,027 $7.07 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $725,985 - $807,840	4,500 Added 14.34%	35,889 $5.86 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $25,733 - $28,459	-153 Reduced 0.49%	31,389 $5.57 Million
Q1 2022 May 05, 2022	BUY	$158.14 - $179.59 $75,432 - $85,664	477 Added 1.54%	31,542 $5.59 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $41,945 - $46,539	-269 Reduced 0.86%	31,065 $5.31 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $130,169 - $144,652	806 Added 2.64%	31,334 $5.06 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $81,813 - $87,758	513 Added 1.71%	30,528 $5.03 Million
Q1 2021 May 18, 2021	BUY	$153.07 - $170.48 $184,602 - $205,598	1,206 Added 4.19%	30,015 $4.93 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $53,884 - $61,850	-393 Reduced 1.35%	28,809 $4.53 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $1.08 Million - $1.18 Million	-7,667 Reduced 20.8%	29,202 $4.35 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $48,174 - $58,160	374 Added 1.02%	36,869 $5.19 Million
Q1 2020 May 11, 2020	SELL	$111.14 - $153.99 $263,735 - $365,418	-2,373 Reduced 6.11%	36,495 $4.79 Million
Q4 2019 Feb 11, 2020	SELL	$127.5 - $146.44 $13.7 Million - $15.7 Million	-107,429 Reduced 73.43%	38,868 $5.67 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $2.97 Million - $3.32 Million	-23,372 Reduced 13.78%	146,297 $18.9 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $385,581 - $424,065	-2,940 Reduced 1.7%	169,669 $23.6 Million
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $1.15 Million - $1.27 Million	-9,111 Reduced 5.01%	172,609 $24.1 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $1.31 Million - $1.58 Million	-10,692 Reduced 5.56%	181,720 $23.5 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $14.8 Million - $17.4 Million	-121,508 Reduced 38.71%	192,412 $26.6 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $3.95 Million - $4.36 Million	-33,118 Reduced 9.54%	313,920 $38.1 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $10.3 Million - $12.2 Million	82,601 Added 31.24%	347,038 $44.5 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $892,033 - $976,328	6,798 Added 2.64%	264,437 $36.9 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $818,509 - $855,872	6,322 Added 2.52%	257,639 $33.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	251,317	251,317 $33.2 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.

Account

First Foundation Advisors Johnson & Johnson Transaction History